Form 8-K - Current report:
SEC Accession No. 0001193125-25-277988
Filing Date
2025-11-12
Accepted
2025-11-12 17:17:17
Documents
21
Period of Report
2025-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d945920d8k.htm   iXBRL 8-K 49157
2 EX-4.1 d945920dex41.htm EX-4.1 616172
3 EX-4.3 d945920dex43.htm EX-4.3 640187
4 EX-10.1 d945920dex101.htm EX-10.1 238076
8 GRAPHIC g945920g1112041118580.jpg GRAPHIC 1810
9 GRAPHIC g945920g1112041118717.jpg GRAPHIC 2285
10 GRAPHIC g945920g1112041118851.jpg GRAPHIC 2285
11 GRAPHIC g945920g1112041118986.jpg GRAPHIC 2281
12 GRAPHIC g945920g1112041119125.jpg GRAPHIC 1997
13 GRAPHIC g945920g1112041119334.jpg GRAPHIC 2696
  Complete submission text file 0001193125-25-277988.txt   1966232

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA halo-20251106.xsd EX-101.SCH 2852
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE halo-20251106_lab.xml EX-101.LAB 17234
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE halo-20251106_pre.xml EX-101.PRE 10813
24 EXTRACTED XBRL INSTANCE DOCUMENT d945920d8k_htm.xml XML 3532
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 251474274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)